Zheng C, Wu J, Li N, Wei X, et al. Cost-effectiveness of finerenone added to standard of care for patients with type 2 diabetes-related chronic kidney disease in the United States. Diabetes Obes Metab 2024 Oct 8. doi: 10.1111/dom.15997.
PMID: 39377137